自然に発生するMTA1変異体は,細胞質中のエストロゲン受容体αを隔離する
Rakesh Kumar1, Rui-An Wang, Abhijit Mazumdar
1Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. rkumar@mdanderson.org
Nature
|August 9, 2002
まとめ
転移性腫瘍抗原1 (MTA1s) の新しい短い形態は,細胞質内のエストロゲン受容体 (ER) を隔離し,乳がんの悪性腫瘍を促進します. このMTA1sによるERの細胞質捕獲は,ERの核機能を阻害し,がんの進行を促します.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
背景:
- エストロゲン受容体 (ER) は,乳がん治療における重要な予後マーカーである.
- 転移性腫瘍抗原1 (MTA1) のアップレギュレーションは,様々ながんの侵入性および転移の可能性と相関し,ER-α共抑制剤として作用する.
研究 の 目的:
- MTA1 (MTA1s) の新しい短い形態を特定し,特徴づけ,ERの調節と乳がんの進行におけるその役割を明らかにする.
- MTA1sがERの局所化と機能に影響を与えるメカニズムを調査する.
主な方法:
- ER-結合モチーフ (LRILL) を含むユニークな33アミノ酸配列を有するMTA1sの識別.
- 乳がん細胞におけるMTA1sの局所化,ERの相互作用,および機能的影響の分析.
- 人間の乳がんにおけるMTA1s発現の調査.
主要な成果:
- MTA1sはサイトプラズマに局所化し,ERに結合し,それを隔離し,核転位を防止し,非ゲノム的なER応答を強化します.
- MTA1sにおけるLRILLモチーフの削除は,ERの相互作用と共同抑制機能を廃止し,ERの核の局所化を復元します.
- ヒトの表皮成長因子受容体-2の調節不良は,MTA1sの発現と乳がん細胞におけるERの細胞質連鎖を強化する.
- MTA1sの発現は悪性現象型と相関しており,低核ERを有するヒト乳腺腫瘍では上昇しています.
結論:
- MTA1sは,細胞質のER結合タンパク質として作用し,ERシグナル伝達を妨害し,乳がんの悪性腫瘍を促進します.
- MTA1sとERの相互作用は,核排斥を通じて核受容体シグナル伝達を調節するための新しいメカニズムを表しています.
- MTA1sまたはERとの相互作用をターゲットにすることで,乳がんに対する新しい治療戦略を提供することができます.
関連する概念動画
01:08Intracellular Hormone Receptors
Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
01:45Tail-anchoring of Proteins in the ER Membrane
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
01:28Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...